Analysis of the post-incorporation period of health technologies incorporated into the SUS, from 2012 to 2022
DOI:
https://doi.org/10.11606/s15188787.2025059006732Keywords:
Brazilian Unified Health System, Health Technolog, Access to Health TechnologiesAbstract
OBJECTIVE: To analyze the time elapsed in the post-incorporation process of procedures, orthoses, prostheses, and special materials, with a focus on compliance with the legal deadline of 180 days established for the provision of the technology. METHODS: The analysis was conducted with procedures and orthoses, prostheses, and special materials recommended for incorporation by the National Commission for the Incorporation of Technologies from 2012 to 2022, and the technology identification code created in the Management System for the Table of Procedures, Medicines, Orthoses, Prostheses and Special Materials of the Brazilian Unified Health System, after incorporation. For the technologies identified, we calculated the median periods (Q1–Q3) of the days elapsed during the incorporation and post-incorporation periods. In addition, the proportion of technologies offered according to the legal deadline was verified, and the influence of variables on the post-incorporation period was analyzed. RESULTS: Among 41 reports on procedures, orthoses, prostheses, and special selected materials, 79 technologies were analyzed. The coding period, defined as the benchmark for the supply of the technology, had a median of 204 (57–425) days. This period was longer than 180 days in 64% of the technologies assessed. Variables such as the organization group to which the technology belongs, indication of the need to adapt for implementation in the incorporation report, and delay in the evaluation period for incorporation seem to influence the period for providing the technology. CONCLUSIONS: The effective provision of technologies incorporated into the health system in Brazil has not occurred within the expected period of 180 days in most cases, which limits their accessibility to the population. Anticipating the need for adaptation before implementation, even during incorporation, seems to be a way of reducing the post-incorporation period.
References
World Health Organization. Monitoring the building blocks of health systems: a handbook of indicators and their measurement strategies. Geneva: WHO; 2010.
Mendis S, Fukino K, Cameron A, Laing R, Filipe Jr A, Khatib O, et al. The availability and affordability of selected essential medicines for chronicl diseases in six low- and middle-income countries. Bull World Health Organ. 2007 abr;85(4):279–88. https://doi.org/10.2471/blt.06.033647
Baird LG, Banken R, Eichler HG, Kristensen FB, Lee DK, Lim JCW, et al. Accelerated access to innovative medicines for patients in need. Clin Pharmacol Ther. 2014 nov;96(5):559–71. https://doi.org/10.1038/clpt.2014.145
Ministério da Saúde (BR). Fluxo de incorporação de tecnologias no SUS [Internet]. Brasília, DF: Ministério da Saúde; 2023 [cited 2025 Jun 18]. Available from: https://www.gov.br/conitec/pt-br/ assuntos/fluxo-de-incorporacao-de-tecnologias-no-sus
Brasil. Lei n. 12401, de 28 de abril de 2011. Altera a Lei no 8.080, de 19 de setembro de 1990, para dispor sobre a assistência terapêutica e a incorporação de tecnologia em saúde no âmbito do Sistema Único de Saúde – SUS. Diário Oficial União [Internet]. 28 abr. 2011 [cited 2025 Jun 18]. Available from: https://www.planalto.gov.br/ccivil_03/_ ato2011-2014/2011/lei/l12401.htm
Capucho HC, Brito A, Maiolino A, Kaliks RA, Pinto RP. Incorporação de medicamentos no SUS: comparação entre oncologia e componente especializado da assistência farmacêutica. Ciênc Saúde Coletiva. 2022 jun;27(6):2471–9. https://doi.org/10.1590/1413-81232022276.16282021
Lupatini EDO, Zimmermann IR, Barreto JOM, Silva EN. How long does it take to translate research findings into routine healthcare practice? The case of biological drugs for rheumatoid arthritis in Brazil. Ann Transl Med. 2022 jul;10(13):738. https://doi.org/10.21037/atm-22-397
Xavier LC, Elias FTS. Análise dos prazos de oferta dos medicamentos incorporados no Componente Especializado da Assistência Farmacêutica, entre 2012 e 2016. BIS. 2023 dez;24(2):179–88. https://doi.org/10.52753/bis.v24i2.40178
Controladoria-Geral da União (CGU). Relatório de avaliação. Processo de incorporação de tecnologias em saúde [Internet]. 2021 [cited 2025 Jun 18]. Available from: https://www.gov. br/conitec/pt -br/midias/auditorias/relatorio_avaliacao_cgu-processo-de-incorporacao-detecnologias-em-saude.pdf
Pinheiro D, Belmiro C, Reis BS. Oferta de tecnologia em saúde no Brasil: síntese de evidências nacionais [Internet]. 2022 [cited 2025 Jun 18]. Available from: http://repositorio.enap.gov.br/ handle/1/7753
Ministério da Saúde (BR). Painel de recomendações da Conitec [Internet]. 2025 [cited 2025 Mar 12]. Available from: https://www.gov.br/conitec/pt-br/assuntos/avaliacaode-tecnologias-em-saude/recomendacoes-conitec
Rodrigues Filho FJ, Pereira MC. O perfil das tecnologias em saúde incorporadas no SUS de 2012 a 2019: quem são os principais demandantes? Saúde debate. 2021 set;45(130):707–19. https://doi.org/10.1590/0103-1104202113011
R Core Team. R: a language and environment for statistical computing [Internet]. 2015 [cited 2020 Oct 3]. Available from: https://www.R-project.org/
Ministério da Saúde (BR). Manual de boas práticas de gestão das Órteses, Próteses e Materiais Especiais (OPME). Brasília, DF: Ministério da Saúde; 2016.
Contó M, Biella CA, Petramale CA. Dispositivos médicos no Sistema Único de Saúde (SUS) – avaliação e incorporação tecnológica. Rev G&Saude. 2015;6:3016–23.
Drummond M, Tarricone R, Torbica A. Incentivizing research into the effectiveness of medical devices. Eur J Health Econ. 2016 dez;17(9):1055–8. https://doi.org/10.1007/s10198-016-0820-3
Ministério da Saúde (BR). Diretrizes Metodológicas: elaboração de estudos para avaliação de equipamentos médico-assistenciais. Brasília, DF: Ministério da Saúde; 2013.
Taylor RS, Iglesias CP. Assessing the clinical and cost-effectiveness of medical devices and drugs: are they that different? Value Health. 2009 jun;12(4):404–6. https://doi.org/10.1111/j.1524-4733.2008.00476_2.x
Ministério da Saúde (BR). Decreto n. 7.646, de 21 de dezembro de 2011. Dispõe sobre a Comissão Nacional de Incorporação de Tecnologias no Sistema Único de Saúde e sobre o processo administrativo para incorporação, exclusão e alteração de tecnologias em saúde pelo Sistema Único de Saúde – SUS, e dá outras providências. Diário Oficial da União [internet]. 21 dez. 2011 [cited 2025 Jun 18]. Available from: https://www.planalto.gov.br/ ccivil_03/_ato2011-2014/2011/decreto/d7646.htm
Aguillar A, Leal F, Thami H, Nobre V. Panorama da inovação em saúde no Brasil. Rio de Janeiro: IEPS; 2021.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Nayê Balzan Schneider, Ana Paula Beck Da Silva Etges, Carisi Anne Polanczyk
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
Funding data
-
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Grant numbers funding code 001
